Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



GRAINGER DAVID J Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 4,700 shares @ $6.47, valued at $30.4k
07/03/2023 4 GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 4,290 shares @ $5.9001, valued at $25.3k
04/04/2023 4 GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 4,825 shares @ $3.9, valued at $18.8k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2023 4 GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 7,154 shares @ $4.25, valued at $30.4k
01/04/2023 4 GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Paid exercise price by delivering 2,497 shares @ $3.1, valued at $7.7k
11/23/2022 4/A GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
10/04/2022 4 GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Sold 2,328 shares @ $4.0674, valued at $9.5k
Sold 2,853 shares @ $3.9501, valued at $11.3k
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2022 4 GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Bought 27,500 shares @ $9.0456, valued at $248.8k
11/02/2021 4 GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns: Granted 175,000 options to buy @ $14.01, valued at $2.5M
10/08/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy